Back to Search
JORDAN POSEY, PHARMD
PHARMD
Pharmacist
NPI: 1992074678Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Characterization of the twin-arginine translocase secretion system of Mycobacterium smegmatis.
PMID 16452415·J Bacteriol·2006
8-other
Phase 1 study of weekly polyethylene glycol-camptothecin in patients with advanced solid tumors and lymphomas.
PMID 16278410·Clin Cancer Res·2005
3-trial
Phase-I dose escalation and sequencing study of docetaxel and continuous infusion topotecan in patients with advanced malignancies.
PMID 15838660·Cancer Chemother Pharmacol·2005
3-trial
Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer.
PMID 12750291·Cancer Res·2003
8-other
A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma.
PMID 12684400·Clin Cancer Res·2003
3-trial
A phase I trial of the single-chain immunotoxin SGN-10 (BR96 sFv-PE40) in patients with advanced solid tumors.
PMID 12374676·Clin Cancer Res·2002
3-trial
A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer.
PMID 11385959·Cancer Biother Radiopharm·2001
3-trial
Signet ring cell carcinoma of a pulled-through sigmoid colon mimicking a primary invasive bladder tumor: case report and review of the literature.
PMID 10840481·Urology·2000
5-case
Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer.
PMID 19652054·J Clin Oncol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 JEFFERSON AVE SE
GRAND RAPIDS, MI 49503 - Phone
- (616) 685-1829
Quick Facts
- NPI
- 1992074678
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile